title: From START to finish: implications of the START study.
authors.affiliation: Centers for Disease Control and Prevention, Village Market 00621, Nairobi, Kenya. Electronic address: kmd2@cdc.gov.
authors.forename: Kevin M
authors.initials: KM
authors.lastname: De Cock
authors.affiliation: ICAP at Columbia University, Mailman School of Public Health, New York, NY, USA.
authors.forename: Wafaa M
authors.initials: WM
authors.lastname: El-Sadr
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D010349:Patient Compliance; D065129:Pre-Exposure Prophylaxis; D016032:Randomized Controlled Trials as Topic
chemical_list: D019380:Anti-HIV Agents